Lorena Raquel Lerner, Chief Officer of Keros Therapeutics KROS, has filed 0 purchases and 1 sale on the open market. Over the past 12 months that comes to a net sale of $63.3K. The latest trade was on 02/24.

LL

LL

Lorena Raquel Lerner

Chief Scientific Officer

Company

Keros Therapeutics KROS

First filing

26/02/26

Trades

2 trades

Buys / sales

0 / 1

12-month net buying

−$63.3K

Last trade

02/24

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Keros TherapeuticsKROS	Open-market sale	02/18	02/20	3,873 sh	$16.35	$63,323.55	−11.1%